Trouble reading this email? View it in your browser
European Federation of Pharmaceutical Industries and Associations EFPIA Newsletter 20 March 2025
      Cancer care 2025: an overview of cancer outcomes data across Europe
 
 
Read the full report
 

Despite data showing that cancer is on track to become the leading cause of death in the EU by 2035, encouraging signs are emerging.

The first in depth look at cancer comparisons since 2019 by The Swedish Institute for Health Economics’ (IHE) new report shows that the number of cancer deaths is stabilising, with 12 EU countries seeing a decline in deaths (per 100,000), signalling a turning point in the fight against the disease. Overall, cancer deaths in Europe have stabilized at around 1.3-1.4 million annually since 2008.

The research shows that cancer survival rates have improved across Europe, but disparities between countries – as well as types of cancers – remain.

Read more →
 
 
      News
 
  17 March 2025 Harnessing RWE to transform healthcare decision-making in Europe

EFPIA vision on the role and use of RWE in decision-making

Read more →
 
 
 
      Discover MEPs' views on how to create a healthier, more competitive Europe
 
 
 
Interview with MEP Nicolas Gonzalez Casares

In this brief interview, MEP Nicolas Gonzalez Casares talks about the steps we can take to improve Europe's health in the next EU mandate.

 
 
Interview with MEP Tomislav Sokol

Watch this short interview with MEP Tomislav Sokol where he outlines his vision for ensuring health remains a top priority in the next EU mandate.

 
 
 
 
      Events
 
 
24 MAR 2025
  Lp(a) Global Summit 2025 Brussels, Belgium

The Lp(a) Global Summit 2025 is an exclusive, high-level event dedicated to shaping the future of cardiovascular health...

Learn more →
 
 
 
03 APR 2025
  Unlocking efficiency through reliance: Navigating the EMA post-authorization framework... Virtual event

Register now to join this webinar.

Learn more →
 
 
 
15 APR 2025
  Vaccines & the EU HTA regulation: Why, what and how? Virtual event

With the EU HTA regulation now in force (January 2025), this session will explore the critical need to account for vaccines...

Learn more →
 
 
 
13 MAY 2025
  International conference on protein stability – The gap between industry and administration... Södertälje Science Park, Sweden

The objective of this symposium/conference is to create an arena for discussions on the recent research and industrial...

Learn more →
 
 
      What we are reading
Europe has a platform for driving more flexible clinical trials: It’s time to use it 13 March 2025  (Pharma Boardroom) Read more →
New clinical trial map launched in the EU 03 March 2025  (European Medicines Agency) Read more →
    About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 36 national associations and 39 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

 
Tel: +32 (0)2 626 25 55
Communications@efpia.eu
▶ in
 
EFPIA 2026 All rights reserved  ·  Disclaimer  ·  Unsubscribe